BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17705553)

  • 1. 3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies.
    Garg S; Thopate SR; Minton RC; Black KW; Lynch AJ; Garg PK
    Bioconjug Chem; 2007; 18(5):1612-8. PubMed ID: 17705553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications.
    Haeusler D; Mien LK; Nics L; Ungersboeck J; Philippe C; Lanzenberger RR; Kletter K; Dudczak R; Mitterhauser M; Wadsak W
    Appl Radiat Isot; 2009 Sep; 67(9):1654-60. PubMed ID: 19359188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
    Parsey RV; Ojha A; Ogden RT; Erlandsson K; Kumar D; Landgrebe M; Van Heertum R; Mann JJ
    J Nucl Med; 2006 Nov; 47(11):1796-802. PubMed ID: 17079812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
    Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
    Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
    J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
    Frankle WG; Slifstein M; Gunn RN; Huang Y; Hwang DR; Darr EA; Narendran R; Abi-Dargham A; Laruelle M
    J Nucl Med; 2006 May; 47(5):815-26. PubMed ID: 16644752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved synthesis of 4-[18F]-ADAM, a potent serotonin transporter imaging agent.
    Huang YY; Huang WS; Chu TC; Shiue CY
    Appl Radiat Isot; 2009 Jun; 67(6):1063-7. PubMed ID: 19339192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies.
    Lundquist P; Wilking H; Höglund AU; Sandell J; Bergström M; Hartvig P; Långström B
    Nucl Med Biol; 2005 Feb; 32(2):129-36. PubMed ID: 15721758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
    Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K
    J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of [11C]DASB-synthesis: vessel-based and flow-through microreactor methods.
    Ungersboeck J; Philippe C; Haeusler D; Mitterhauser M; Lanzenberger R; Dudczak R; Wadsak W
    Appl Radiat Isot; 2012 Nov; 70(11):2615-20. PubMed ID: 22940416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.
    Wilson AA; Ginovart N; Hussey D; Meyer J; Houle S
    Nucl Med Biol; 2002 Jul; 29(5):509-15. PubMed ID: 12088720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved HPLC purification strategy for [11C]raclopride and [11C]DASB leading to high radiochemical yields and more practical high quality radiopharmaceutical formulations.
    Van Laeken N; Kersemans K; De Meestere D; Goethals I; De Vos F
    Appl Radiat Isot; 2013 Aug; 78():62-7. PubMed ID: 23676564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.
    Parhi AK; Wang JL; Oya S; Choi SR; Kung MP; Kung HF
    J Med Chem; 2007 Dec; 50(26):6673-84. PubMed ID: 18052090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
    Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
    J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for stabilizing non carrier added 2-[(18)F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation.
    Kersemans K; Bauwens M; Mertens J
    Nucl Med Biol; 2008 May; 35(4):425-32. PubMed ID: 18482679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.
    Funke U; Fischer S; Hiller A; Scheunemann M; Deuther-Conrad W; Brust P; Steinbach J
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4727-30. PubMed ID: 18644726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.
    Wagner S; Breyholz HJ; Law MP; Faust A; Höltke C; Schröer S; Haufe G; Levkau B; Schober O; Schäfers M; Kopka K
    J Med Chem; 2007 Nov; 50(23):5752-64. PubMed ID: 17956082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
    Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
    Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.